Columnist Questions CIRM Board’s Response to Review

During a public meeting on Wednesday, some members of the California Institute for Regenerative Medicine's governing board "showed overt hostility" to new federal recommendations for changes to the agency's leadership and management structures, Los Angeles Times columnist Michael Hiltzik writes. He questions whether "the board will be taking seriously the advice" from the Institute of Medicine, adding, "Stay tuned, but don't hold your breath."

• "Is California's Stem Cell Program Preparing To Waste $700,000?" (Hiltzik, "Money & Co.," Los Angeles Times, 12/12).